Purchase Order 75N93024P00979
Award Date
8/12/24
Potential Completion Date
12/11/24
Potential Value
$11K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Novogene Corporation Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95817, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...
This federal contract award is for $14,072.00 and was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for pre-made libraries lane sequencing services, which involves advanced next-generation sequencing technologies including whole genome, transcriptome, metagenomic, and RNA sequencing. This contract has an ultimate completion date of June 30, 2025 and is a...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $15,900.00 contract will provide plant and animal ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) services utilizing the Illumina NovaSeq PE150 platform. The work will be performed in Sacramento, California and is expected to be...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
This is a firm fixed-price purchase order awarded by the Plains Area division of a civilian federal agency to Novogene Corporation Inc., a minority-owned small business. The contract, valued at $62,346.90, is for genomic sequencing services and covers the period through December 31, 2024. Novogene is a provider of next-generation sequencing technologies, including whole genome, exome, transcriptome, and metagenomic sequencing, and has delivered these services to various government agencies...
This $9,950 firm fixed price purchase order was awarded by the Northeast Area division of a civilian federal agency to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The contract is for mRNA sequencing services, with a period of performance ending on September 30, 2018. Novogene has established itself as a key provider of DNA/RNA sequencing, library preparation, and data analysis services to various government agencies,...